{"id":"ovarian-stimulation","safety":{"commonSideEffects":[{"rate":"1-14","effect":"Ovarian hyperstimulation syndrome (OHSS)"},{"rate":"20-40","effect":"Abdominal pain and bloating"},{"rate":"10-20","effect":"Headache"},{"rate":"10-15","effect":"Nausea"},{"rate":"5-10","effect":"Injection site reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ovarian stimulation typically involves administration of follicle-stimulating hormone (FSH), luteinizing hormone (LH), or human menopausal gonadotropin (hMG) to promote the growth of multiple ovarian follicles. This controlled hyperstimulation allows retrieval of multiple eggs during in vitro fertilization (IVF) or other fertility treatments, increasing the chances of successful conception by providing more oocytes for fertilization.","oneSentence":"Ovarian stimulation uses gonadotropins or other hormonal agents to induce the development and release of multiple oocytes from the ovaries for assisted reproductive procedures.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:35:27.676Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Infertility in women undergoing assisted reproductive technology (ART)"},{"name":"Anovulation or oligoovulation in women seeking pregnancy"}]},"trialDetails":[{"nctId":"NCT05954962","phase":"PHASE4","title":"Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2023-12-23","conditions":"IVF","enrollment":150},{"nctId":"NCT05364008","phase":"PHASE3","title":"FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2023-01-05","conditions":"Leiomyoma, Uterine","enrollment":33},{"nctId":"NCT06378268","phase":"NA","title":"PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-24","conditions":"Progestins Primed Ovarian Stimulation","enrollment":626},{"nctId":"NCT04983173","phase":"PHASE4","title":"INTEnsity of ovariaN Stimulation and Embryo Quality","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-11-23","conditions":"Infertility","enrollment":110},{"nctId":"NCT06433518","phase":"","title":"BEst Size for Ovulation Triggering in Poseidon 4 Patients (BEST 4 Study)","status":"RECRUITING","sponsor":"Centrum Clinic IVF Center","startDate":"2026-03-15","conditions":"Fertilization, Fertilization in Vitro","enrollment":200},{"nctId":"NCT07216742","phase":"PHASE3","title":"Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.","status":"RECRUITING","sponsor":"Granata Bio Corporation","startDate":"2025-11-01","conditions":"Infertility (IVF Patients)","enrollment":659},{"nctId":"NCT06581068","phase":"NA","title":"Automation of the In Vitro Fertilization Laboratory","status":"RECRUITING","sponsor":"Conceivable Life Sciences","startDate":"2024-12-03","conditions":"Infertility, ART","enrollment":150},{"nctId":"NCT02871167","phase":"NA","title":"Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2016-12","conditions":"Breast Cancer","enrollment":140},{"nctId":"NCT07340827","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)","status":"RECRUITING","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2026-02-05","conditions":"Infertility","enrollment":333},{"nctId":"NCT04948658","phase":"","title":"Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy","status":"RECRUITING","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2021-09-13","conditions":"Turner Syndrome, Post-menarcheal Adolescents, Ovarian Disfunction","enrollment":200},{"nctId":"NCT05479045","phase":"PHASE2","title":"A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"Georgetown University","startDate":"2026-09","conditions":"Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3","enrollment":24},{"nctId":"NCT07153367","phase":"PHASE2","title":"Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE)","status":"RECRUITING","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2025-12-17","conditions":"Infertility, Insemination","enrollment":80},{"nctId":"NCT07466199","phase":"PHASE4","title":"Exogenous Progesterone as Ovulation Trigger","status":"NOT_YET_RECRUITING","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2026-04","conditions":"Ovulation, Ovarian Function, Assisted Reproductive Treatments","enrollment":10},{"nctId":"NCT07462065","phase":"PHASE4","title":"Effect Clomiphene vs Clomiphene Along With Pioglitazone on Ovarian Stimulation Rate","status":"RECRUITING","sponsor":"PAEC General Hospital, Islamabad","startDate":"2026-03-01","conditions":"Infertility Treatment, Pregnancy Rates","enrollment":62},{"nctId":"NCT07460674","phase":"","title":"Serum FSH Levels During Controlled Ovarian Stimulation","status":"NOT_YET_RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2026-02-16","conditions":"Female Subjects Undergoing Controlled Ovarian Hyperstimulation","enrollment":500},{"nctId":"NCT07450300","phase":"","title":"Assessment of the Feasibility of Frozen Embryo Transfers in a Natural Cycle Among Obese Compared to Non-Obese Patients","status":"COMPLETED","sponsor":"Clinique Mathilde","startDate":"2022-11-01","conditions":"Infertility, Female","enrollment":1831},{"nctId":"NCT07448272","phase":"NA","title":"Letrozole 5 mg for 10 Days Versus Letrozole 10 mg for 5 Days for Ovarian Stimulation in PCOS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mst.Sumyara Khatun","startDate":"2025-04-01","conditions":"PCOS (Polycystic Ovary Syndrome)","enrollment":80},{"nctId":"NCT05277948","phase":"NA","title":"Effect of Thumbtack Needle (TN) on Ovarian Reserve Function of Women With Diminished Ovarian Reserve (DOR)","status":"COMPLETED","sponsor":"Dongmei Huang","startDate":"2021-10-18","conditions":"Diminished Ovarian Reserve","enrollment":240},{"nctId":"NCT07423143","phase":"NA","title":"Menopausal Impact of Opportunistic Salpingectomy for Ovarian Cancer Prevention","status":"NOT_YET_RECRUITING","sponsor":"Umeå University","startDate":"2026-03","conditions":"Menopause, Opportunistic Salpingectomy","enrollment":2100},{"nctId":"NCT06561958","phase":"","title":"Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settings","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ferring Pharmaceuticals","startDate":"2024-08-27","conditions":"Infertility","enrollment":1500},{"nctId":"NCT07409493","phase":"NA","title":"IVF Outcomes With Time-Lapse Culture: Comparison Between PPOS and GnRH Antagonist Protocols","status":"RECRUITING","sponsor":"Hanoi Medical University","startDate":"2026-01-21","conditions":"Infertility (IVF Patients), Embryo Morphokinetics, Progestins Primed Ovarian Stimulation","enrollment":148},{"nctId":"NCT06173869","phase":"PHASE3","title":"A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2024-03-29","conditions":"Infertility, Female","enrollment":301},{"nctId":"NCT07402473","phase":"PHASE2","title":"EUREKA Study:Phase 2 Study to Optimize Neoadjuvant Therapy in HER2-positive Early-stage Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2026-03-01","conditions":"HER2-positive Early-stage Breast Cancer","enrollment":50},{"nctId":"NCT07331493","phase":"","title":"Establishing a Minimum Predictive Threshold Follicular Size and Oocyte Retrieval in ICSI Cycle","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04-30","conditions":"Female Infertility","enrollment":60},{"nctId":"NCT07394530","phase":"NA","title":"Comparison of IVF Outcomes Between PPOS and Antagonist Protocols in Women With PCOS","status":"RECRUITING","sponsor":"Hanoi General Hospital (Vietnam)","startDate":"2026-01-20","conditions":"Polycystic Ovary Syndrome (PCOS), Female Infertility","enrollment":400},{"nctId":"NCT07376460","phase":"","title":"Proteomic and Biological Characterisation of Plasma for the Study of Changes Following Ovarian Reactivation Treatment","status":"NOT_YET_RECRUITING","sponsor":"Instituto Valenciano de Infertilidad, IVI Alicante","startDate":"2026-02","conditions":"Poor Ovarian Response, Ovarian Reactivation","enrollment":10},{"nctId":"NCT07348757","phase":"","title":"rFSH vs rFSH+rLH in Dydrogesterone-Based Progestin Protocol: A Prospective Study","status":"RECRUITING","sponsor":"Centrum Clinic IVF Center","startDate":"2026-01-05","conditions":"InVitro Fertilization, Gonadotropins","enrollment":300},{"nctId":"NCT05326087","phase":"PHASE3","title":"Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A","status":"NOT_YET_RECRUITING","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2026-06-01","conditions":"Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation, Polycystic Ovarian Syndrome","enrollment":204},{"nctId":"NCT04002141","phase":"PHASE2","title":"Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2019-09-17","conditions":"Endometriosis, Ovarian Hyperstimulation","enrollment":60},{"nctId":"NCT07148141","phase":"","title":"Impact of Breast Cancer on Human Folliculogenesis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2019-01-11","conditions":"Breast Cancer Female, Infertility, Female","enrollment":100},{"nctId":"NCT06781957","phase":"PHASE1","title":"Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2024-09-15","conditions":"OVARIAN STIMULATION, Infertility","enrollment":29},{"nctId":"NCT07242534","phase":"PHASE4","title":"Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.","status":"RECRUITING","sponsor":"Fundacion Dexeus","startDate":"2026-01-19","conditions":"Infertility, Obesity","enrollment":62},{"nctId":"NCT07347340","phase":"PHASE3","title":"Testing Herbal Pretreatment For IVF Success In Women With Low Ovarian Reserve","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-01-01","conditions":"Diminished Ovarian Reserve (DOR)","enrollment":348},{"nctId":"NCT07346235","phase":"PHASE3","title":"150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial","status":"NOT_YET_RECRUITING","sponsor":"American Hospital 2 Kosovo","startDate":"2026-03-01","conditions":"Infertility, Female","enrollment":440},{"nctId":"NCT07110285","phase":"NA","title":"Ovarian Stimulation Outcomes During a GnRH Antagonist Protocol for In-vitro Fertilization When Comparing Trigger Day Decision by Physicians Versus an Artificial Intelligence-based Algorithm.","status":"RECRUITING","sponsor":"FertilAI","startDate":"2025-05-21","conditions":"IVF Outcomes","enrollment":180},{"nctId":"NCT07318974","phase":"PHASE2","title":"Melatonin Therapy for Improving ICSI Outcomes in Women With Diminished Ovarian Reserve","status":"ACTIVE_NOT_RECRUITING","sponsor":"Benha University","startDate":"2025-09-10","conditions":"ICS","enrollment":64},{"nctId":"NCT04163133","phase":"NA","title":"Trigger Timing in Ovarian Stimulations","status":"RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2020-04-01","conditions":"IVF Outcome","enrollment":834},{"nctId":"NCT05080569","phase":"PHASE4","title":"Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2023-03-01","conditions":"Pregnancy Related, Fertility Issues, Luteal Phase Defect","enrollment":1008},{"nctId":"NCT06175832","phase":"PHASE4","title":"PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2025-01-27","conditions":"Ovarian Stimulation, Quality of Life, Preimplantation Genetic Testing","enrollment":60},{"nctId":"NCT06863337","phase":"NA","title":"Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose Monitoring","status":"RECRUITING","sponsor":"Shanghai 6th People's Hospital","startDate":"2025-03-26","conditions":"Infertility Female","enrollment":100},{"nctId":"NCT05847283","phase":"NA","title":"DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT","status":"RECRUITING","sponsor":"Tam Anh TP. Ho Chi Minh General Hospital","startDate":"2023-06-22","conditions":"Diminished Ovarian Reserve","enrollment":730},{"nctId":"NCT07274202","phase":"NA","title":"The Physical and Mental Impact of ART: IVM vs Conventional Ovarian Stimulation","status":"NOT_YET_RECRUITING","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2026-01","conditions":"PCOS (Polycystic Ovary Syndrome)","enrollment":84},{"nctId":"NCT06984081","phase":"NA","title":"CAPA In-vitro Oocyte Maturation","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-11-10","conditions":"Infertility, Female","enrollment":100},{"nctId":"NCT05316129","phase":"PHASE1","title":"Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2022-04-28","conditions":"Ovarian Cancer","enrollment":10},{"nctId":"NCT04166825","phase":"NA","title":"Ovarian Hyperstimulation and Fibrin Clot Properties.","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2019-11-18","conditions":"Fibrin Blood Clot, Infertility, Female, Endometriosis","enrollment":300},{"nctId":"NCT02892942","phase":"PHASE4","title":"NATural Ovarian Stimulation","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-01-13","conditions":"Infertility","enrollment":129},{"nctId":"NCT07240363","phase":"NA","title":"First Line Surgery or First Line Fertility Treatment Using Assisted Reproductive Technologies in Patients With Advanced Endometriosis","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2025-10-06","conditions":"Endometriosis, Infertility Assisted Reproductive Technology","enrollment":350},{"nctId":"NCT06817161","phase":"PHASE3","title":"Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer:","status":"RECRUITING","sponsor":"Centre Francois Baclesse","startDate":"2025-04-30","conditions":"Ovarian Carcinoma, First Line Chemotherapy, Digestive System Disorders","enrollment":116},{"nctId":"NCT06466486","phase":"PHASE1","title":"An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation","status":"TERMINATED","sponsor":"Ferring Pharmaceuticals","startDate":"2024-06-14","conditions":"Fertility","enrollment":310},{"nctId":"NCT06877429","phase":"","title":"Is the Diurnal Variation in Circulating Levels of Cortisol Reflected in Follicular Fluid of Preovulatory Follicles Close to Ovulation?","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":"Healthy","enrollment":20},{"nctId":"NCT06511791","phase":"PHASE1","title":"An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.","status":"TERMINATED","sponsor":"Ferring Pharmaceuticals","startDate":"2024-07-15","conditions":"Infertility","enrollment":106},{"nctId":"NCT06879002","phase":"","title":"Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":"Stimulation in the Ovary, IVF Outcome","enrollment":252},{"nctId":"NCT07171970","phase":"NA","title":"IVM - Fresh ET (THE SAIGON PROTOCOL) Versus IVF - FET in PCOS Women","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2025-09-22","conditions":"Polycystic Ovary Syndrome (PCOS), In Vitro Maturation of Oocytes, Fresh Embryo Transfer","enrollment":600},{"nctId":"NCT06023602","phase":"NA","title":"Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF","status":"RECRUITING","sponsor":"Northwest Women's and Children's Hospital, Xi'an, Shaanxi","startDate":"2024-02-27","conditions":"Infertility","enrollment":1338},{"nctId":"NCT07108621","phase":"PHASE3","title":"hCG Priming in Women With Diminished Ovarian Reserve","status":"RECRUITING","sponsor":"Kristine Loessl","startDate":"2025-09","conditions":"Infertility, Female, Ovarian Reserve, In Vitro Fertilization (IVF)","enrollment":80},{"nctId":"NCT06193135","phase":"NA","title":"Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA)","status":"RECRUITING","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2025-07-08","conditions":"Infertility, Female, Reproductive Sterility","enrollment":318},{"nctId":"NCT03241329","phase":"","title":"Endometriosis Impact on Oocyte Quality","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-02-26","conditions":"Endometriosis","enrollment":16},{"nctId":"NCT06701071","phase":"PHASE4","title":"Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation","status":"RECRUITING","sponsor":"University of Southern California","startDate":"2025-06-01","conditions":"Infertility, Female","enrollment":120},{"nctId":"NCT04710264","phase":"","title":"Aurora Test for Patients Treated With Recombinant Gonadotropins","status":"COMPLETED","sponsor":"Fertiga, Belgium","startDate":"2021-02-15","conditions":"Infertility","enrollment":137},{"nctId":"NCT07142187","phase":"NA","title":"The Clinical Trial of Electro-thumbtack Needle on Live Birth Rate in Patients With Ovarian Reserve Dysfunction (DOR)","status":"NOT_YET_RECRUITING","sponsor":"Huazhong University of Science and Technology","startDate":"2025-10-01","conditions":"Diminished Ovarian Reserve (DOR)","enrollment":368},{"nctId":"NCT06604091","phase":"","title":"Cohort Profile：The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart)","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Second Hospital of Shandong University","startDate":"2024-06-30","conditions":"Adenomyosis, in Vitro Fertilization","enrollment":2241},{"nctId":"NCT06545877","phase":"","title":"REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)","status":"RECRUITING","sponsor":"Ferring Pharmaceuticals","startDate":"2022-09-16","conditions":"Infertility","enrollment":500},{"nctId":"NCT07128394","phase":"NA","title":"Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment","status":"RECRUITING","sponsor":"Nanjing University","startDate":"2024-02-01","conditions":"Infertility, Female, Luteinizing Hormone (LH)","enrollment":590},{"nctId":"NCT07121751","phase":"PHASE4","title":"Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)","status":"NOT_YET_RECRUITING","sponsor":"Dunamenti REK Istenhegyi IVF Center","startDate":"2025-09-01","conditions":"Hypo-responder, Infertility (IVF Patients), OVARIAN STIMULATION","enrollment":150},{"nctId":"NCT07117682","phase":"NA","title":"Safety and Efficacy of Autologous Adipose-Derived Regenerative Cells (ADRCs) Injection for Improving Diminished Ovarian Reserve","status":"NOT_YET_RECRUITING","sponsor":"Cytori Therapeutics","startDate":"2025-08-25","conditions":"Diminished Ovarian Reserve (DOR), Primary Ovarian Insufficiency (Poi), Ovarian Failure, Premature","enrollment":25},{"nctId":"NCT05293366","phase":"","title":"LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":"Long Covid-19","enrollment":100},{"nctId":"NCT03307356","phase":"NA","title":"The University of Pennsylvania Uterus Transplant for Uterine Factor Infertility Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2018-01-10","conditions":"Mayer Rokitansky Kuster Hauser Syndrome, Uterine Agenesis, Infertility, Female, of Uterine Origin","enrollment":10},{"nctId":"NCT06995261","phase":"","title":"Follitropin Delta in Long GnRH-agonist Protocol","status":"RECRUITING","sponsor":"Prof. Dr. med. M.Sc. Georg Griesinger","startDate":"2025-07-09","conditions":"Infertility (IVF Patients), Infertility, Infertility Drugs","enrollment":350},{"nctId":"NCT07085312","phase":"NA","title":"Exosome-Enriched Culture Media to Enhance In Vitro Maturation and Embryo Development in Poor Ovarian Responders Undergoing IVF","status":"COMPLETED","sponsor":"Fertiaguerrevere","startDate":"2023-07-02","conditions":"Poor Ovarian Response, Female Infertility of Other Origin, Oocyte Immaturity","enrollment":10},{"nctId":"NCT06732843","phase":"","title":"Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-07-23","conditions":"OVARIAN STIMULATION, Telomere Length, Telomere Length, Mean Leukocyte","enrollment":10},{"nctId":"NCT07083427","phase":"NA","title":"CAPA In-vitro Oocyte Maturation (CUHK Medical Centre Limited)","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-08-01","conditions":"Infertility, Female","enrollment":50},{"nctId":"NCT01510054","phase":"","title":"Endometrial Luteal Phase Characteristics and Luteal Phase Support in Controlled Ovarian Stimulation Protocols With GnRH Antagonists:Focusing on MicroRNA","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2002-07","conditions":"Controlled Ovarian Stimulation","enrollment":""},{"nctId":"NCT07076719","phase":"","title":"Cell-free DNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for Preimplantation Genetic Diagnosis","status":"COMPLETED","sponsor":"Sohag University","startDate":"2023-10-01","conditions":"to Evaluate the Feasibility and Accuracy of Using cfDNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for PGD","enrollment":20},{"nctId":"NCT05807256","phase":"","title":"Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases","status":"RECRUITING","sponsor":"IRCCS San Raffaele","startDate":"2022-05-04","conditions":"Rheumatic Diseases, Fertility Disorders, Pregnancy, High Risk","enrollment":500},{"nctId":"NCT06975683","phase":"NA","title":"Open, Non-comparative Pilot Study to Evaluate the Safety and Efficacy of Intraovarian Plasma Rich in Growth Factors (PRGF) in Patients With Low Ovarian Reserve","status":"RECRUITING","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2025-05-30","conditions":"Low Ovarian Reserve","enrollment":50},{"nctId":"NCT06910293","phase":"","title":"Whole-Brain Dynamics in the Natural Menstrual Cycle vs. an Ovarian Stimulated Cycle: Impact of Hormonal Fluctuations on Healthy Women Undergoing Ovarian Stimulation","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-04-07","conditions":"Neural Activity, Brain Function, Neurodynamics","enrollment":15},{"nctId":"NCT03680053","phase":"NA","title":"Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF","status":"TERMINATED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2020-04-10","conditions":"Infertility, ART","enrollment":220},{"nctId":"NCT04414748","phase":"PHASE3","title":"Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-A","status":"COMPLETED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2020-06-10","conditions":"Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation, Euploid Rate","enrollment":400},{"nctId":"NCT06244745","phase":"PHASE3","title":"Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors.","status":"RECRUITING","sponsor":"IVI Madrid","startDate":"2023-12-15","conditions":"Luteinised Follicular Cyst","enrollment":152},{"nctId":"NCT05815719","phase":"PHASE4","title":"Continuous Double Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2022-11-17","conditions":"Fertility Issues","enrollment":30},{"nctId":"NCT06195163","phase":"PHASE4","title":"TRAP Study: Testosterone for Androgen Receptor Polymorphism","status":"NOT_YET_RECRUITING","sponsor":"Instituto Bernabeu","startDate":"2025-09-30","conditions":"Fertility Disorders","enrollment":100},{"nctId":"NCT06117982","phase":"PHASE2","title":"The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency","status":"COMPLETED","sponsor":"Trio Fertility","startDate":"2023-10-13","conditions":"Primary Ovarian Insufficiency, Premature Ovarian Failure","enrollment":11},{"nctId":"NCT06950476","phase":"","title":"ART Cycle Outcomes When Only 1 to 3 Oocytes Are Retrieved","status":"COMPLETED","sponsor":"Istituto Clinico Humanitas","startDate":"2010-01-01","conditions":"Infertility Assisted Reproductive Technology, Oocyte Retrieval","enrollment":3761},{"nctId":"NCT06933901","phase":"","title":"Impact of the Operator Performing Oocyte Retrieval on the Cumulative Live Birth Rate","status":"COMPLETED","sponsor":"Istituto Clinico Humanitas","startDate":"2013-01-01","conditions":"Infertility (IVF Patients), Oocyte Retrieval","enrollment":19500},{"nctId":"NCT03610490","phase":"PHASE2","title":"Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-10-16","conditions":"Malignant Solid Neoplasm, Metastatic Colorectal Adenocarcinoma, Metastatic Ovarian Carcinoma","enrollment":16},{"nctId":"NCT06921395","phase":"PHASE4","title":"Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).","status":"RECRUITING","sponsor":"LG Chem","startDate":"2025-02-15","conditions":"Female Infertility","enrollment":248},{"nctId":"NCT06839274","phase":"","title":"Follicular Volume at the Time of Final Oocyte Maturation in Poor Responders, and Its Correlation With Oocyte Maturity","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-03-27","conditions":"OVARIAN STIMULATION","enrollment":100},{"nctId":"NCT06321107","phase":"","title":"Long-term Follow-up Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference","status":"ACTIVE_NOT_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2024-03-01","conditions":"Infertility","enrollment":158},{"nctId":"NCT00436254","phase":"PHASE1","title":"Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer","status":"COMPLETED","sponsor":"University of Washington","startDate":"2001-10","conditions":"HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor","enrollment":66},{"nctId":"NCT05263388","phase":"PHASE3","title":"A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2022-07-15","conditions":"Infertility","enrollment":302},{"nctId":"NCT05173597","phase":"","title":"Real-world Evidence on Follitropin Delta Individual Dosing","status":"RECRUITING","sponsor":"University of Luebeck","startDate":"2021-12-08","conditions":"Infertility, Sterility","enrollment":850},{"nctId":"NCT03737253","phase":"NA","title":"Hormone Evaluation in Artificial Reproductive Technology","status":"COMPLETED","sponsor":"Lund University","startDate":"2016-09","conditions":"Female Infertility","enrollment":810},{"nctId":"NCT06878053","phase":"NA","title":"Benefit of Ethanol Sclerotherapy of Endometriomas Before Ovarian Stimulation on Pregnancy Rates in IVF/ICSI","status":"NOT_YET_RECRUITING","sponsor":"Poissy-Saint Germain Hospital","startDate":"2025-06-01","conditions":"Infertile Women Undergoing IVF or ICSI","enrollment":174},{"nctId":"NCT06868576","phase":"PHASE3","title":"PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical Trial","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2023-01-03","conditions":"PPOS, GnRH Antagonist, Assisted Reproductive Techniques","enrollment":328},{"nctId":"NCT06792266","phase":"","title":"CircularRNA-microRNA-mRNA Regulatory Axis in IVF","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-03","conditions":"Infertility (IVF Patients)","enrollment":56},{"nctId":"NCT02496754","phase":"NA","title":"Follicular Long GnRH Agonist Versus Antagonist Protocol in PCOS Women Undergoing in Vitro Fertilization","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2016-06","conditions":"Clinical Pregnancy Rate, Ovulation Induction, IVF","enrollment":1266},{"nctId":"NCT06154083","phase":"PHASE4","title":"INtensity of OVarian Stimualtion and Euploid Embryos","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2023-12-12","conditions":"Fertility","enrollment":110},{"nctId":"NCT06280560","phase":"","title":"Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation","status":"RECRUITING","sponsor":"Fundación IVI","startDate":"2024-02-01","conditions":"Endometrial Receptivity","enrollment":60},{"nctId":"NCT06635538","phase":"NA","title":"One-shot Ovarian Stimulation Protocol (One-shot)","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2024-10-31","conditions":"Infertility, Female","enrollment":20},{"nctId":"NCT03900780","phase":"NA","title":"Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure","status":"RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2019-05-01","conditions":"Recurrent Implantation Failure","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8722,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["controlled ovarian hyperstimulatiom","Follitropine (Puregon)","Ganirelix (Orgalutran)","Triptoreline (Decapeptyl)"],"phase":"marketed","status":"active","brandName":"ovarian stimulation","genericName":"ovarian stimulation","companyName":"Ain Shams Maternity Hospital","companyId":"ain-shams-maternity-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ovarian stimulation uses gonadotropins or other hormonal agents to induce the development and release of multiple oocytes from the ovaries for assisted reproductive procedures. Used for Infertility in women undergoing assisted reproductive technology (ART), Anovulation or oligoovulation in women seeking pregnancy.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}